ClinicalTrials.Veeva

Menu

Effects of Respiratory Muscle Training in People Who Have Had COVID-19 Disease

U

Universidad Complutense de Madrid

Status

Completed

Conditions

Quality of Life
Respiratory Muscle Training
Covid19
Respiratory Function Test
Psychosocial Factor

Treatments

Other: Inspiratory + expiratory muscle training group
Other: Inspiratory + expiratory muscle training placebo group
Other: Inspiratory muscle training placebo group
Other: Inspiratory muscle training group

Study type

Interventional

Funder types

Other

Identifiers

NCT04734561
20/715-E_BS

Details and patient eligibility

About

The main objective of the present study is to observe the short-term effects of respiratory muscle training applied by telerehabilitation on quality of life and exercise tolerance in people who have had the COVID-19 disease. As secondary objectives, the effects on respiratory muscles strength/tolerance, pulmonary function and psychological and cognitive factors.

Full description

It is a double-blind randomized clinical trial study. Each participant will be randomly assigned to one of the following groups: 1) Inspiratory muscle training, 2) Placebo Inspiratory muscle training, 3) Inspiratory muscle training + Expiratory muscle training, 4) Placebo Inspiratory muscle training + Expiratory muscle training.

Each exercise training program will be applied twice per day 7 sessions per week during 8 weeks by a threshold device. The evening sessions will be supervised by a physiotherapist through a virtual platform.

Participants received baseline assessments at the beginning of the intervention, at the end of the 4th week, and post-intervention assessments at the end of the 8th week.

Enrollment

88 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Positive diagnosis of COVID-19 (SARS-CoV2)
  • Hospital admission for COVID-19 in the last 3 months
  • Stable phase and home discharge;

Exclusion criteria

  • Severe cognitive impairment
  • Any type of musculoskeletal, neurological, cardiac or respiratory disease where training is contraindicated
  • Inability to carry out the training program through telematic supervision.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

88 participants in 4 patient groups

Inspiratory muscle training group
Experimental group
Description:
Participants will perform an inspiratory muscle training by a threshold device at home, twice a day for 8 weeks supervised by a physiotherapist through a virtual platform.
Treatment:
Other: Inspiratory muscle training group
Inspiratory muscle training placebo group
Sham Comparator group
Description:
Participants will perform an inspiratory muscle training by a placebo threshold device at home, twice a day for 8 weeks supervised by a physiotherapist through a virtual platform.
Treatment:
Other: Inspiratory muscle training placebo group
Inspiratory + expiratory muscle training group
Experimental group
Description:
Participants will perform an inspiratory and expiratory muscle training by a threshold device at home, twice a day for 8 weeks supervised by a physiotherapist through a virtual platform.
Treatment:
Other: Inspiratory + expiratory muscle training group
Inspiratory + expiratory muscle training placebo group
Sham Comparator group
Description:
Participants will perform an inspiratory and expiratory muscle training by a placebo threshold device at home, twice a day for 8 weeks supervised by a physiotherapist through a virtual platform.
Treatment:
Other: Inspiratory + expiratory muscle training placebo group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems